Vertex Pharmaceuticals (VRTX) News Today $448.01 -19.00 (-4.07%) (As of 11/19/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Jennison Associates LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Jennison Associates LLC increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 18.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,550,386 shares of the pharmaceuticaNovember 20 at 7:16 AM | marketbeat.comVertex Pharmaceuticals Q3 Earnings TranscriptNovember 20 at 7:11 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Holdings Trimmed by MWA Asset ManagementMWA Asset Management lessened its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 43.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 2,583 shares of the pharmaceutical company's stock after selling 2,018 shares during tNovember 20 at 7:06 AM | marketbeat.comNorthwest Bancshares Inc. Has $6.10 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Northwest Bancshares Inc. lessened its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 17.0% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 13,125 shares of the pharmaceutical company's stock after sellingNovember 20 at 6:58 AM | marketbeat.comStrategy Asset Managers LLC Sells 1,805 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Strategy Asset Managers LLC reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 40.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,709 shares of the pharmaceutical compNovember 20 at 6:49 AM | marketbeat.com57,825 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Segall Bryant & Hamill LLCSegall Bryant & Hamill LLC bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 57,825 shares of the pharmaceutical company's stock, valued at approximNovember 20 at 6:49 AM | marketbeat.comProspera Financial Services Inc Has $6.28 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Prospera Financial Services Inc boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 430.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,498 shares of the pharmaceNovember 20 at 5:30 AM | marketbeat.comPathstone Holdings LLC Purchases 2,112 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Pathstone Holdings LLC lifted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,653 shares of the pharmaceutiNovember 20 at 5:06 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Quest Partners LLCQuest Partners LLC raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3,856.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,284 shares of the phaNovember 20 at 4:45 AM | marketbeat.comVertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript)November 19 at 10:26 AM | seekingalpha.comB. Metzler seel. Sohn & Co. Holding AG Invests $18.60 Million in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The firm acquired 39,993 shares of the pharmaceutical company's stock, valued at approximNovember 19 at 9:06 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Banque Cantonale VaudoiseBanque Cantonale Vaudoise boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 354.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,182 shares of the pharmaceutical company's sNovember 19 at 9:05 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by W.G. Shaheen & Associates DBA Whitney & CoW.G. Shaheen & Associates DBA Whitney & Co lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 15.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 43,406 shares of the pharmacNovember 19 at 8:07 AM | marketbeat.com1,424 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Whalen Wealth Management Inc.Whalen Wealth Management Inc. purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,424 shares of the pharmaceuticaNovember 19 at 6:51 AM | marketbeat.comFirst Turn Management LLC Trims Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)First Turn Management LLC decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 30.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,222 sharesNovember 19 at 6:08 AM | marketbeat.comThrivent Financial for Lutherans Sells 3,119 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Thrivent Financial for Lutherans lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,675 shares of the pharmaceuticNovember 19 at 5:02 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by OneDigital Investment Advisors LLCOneDigital Investment Advisors LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 62.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,817 shares of the pharmaceutical company'sNovember 19 at 4:22 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Braun Stacey Associates Inc.Braun Stacey Associates Inc. lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 51,497 shares of the pharmaceutical company'sNovember 18 at 7:21 AM | marketbeat.com3 Growth Stocks You Can Buy Right Now Without Any HesitationNovember 18 at 6:03 AM | fool.comSwiss National Bank Acquires 1,200 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Swiss National Bank grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 0.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 766,000 shares of the pharmaceutical coNovember 17 at 9:06 AM | marketbeat.comAtlanta Consulting Group Advisors LLC Purchases 1,331 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Atlanta Consulting Group Advisors LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 303.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,769 shNovember 17 at 7:26 AM | marketbeat.comEmpowered Funds LLC Sells 17,482 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Empowered Funds LLC decreased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 58.1% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,605 shares of the pharmaceutical company's stock after selling 17,4November 17 at 5:25 AM | marketbeat.comCitigroup Begins Coverage on Vertex Pharmaceuticals (NASDAQ:VRTX)November 17 at 3:17 AM | americanbankingnews.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Natixis Advisors LLCNatixis Advisors LLC lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 461,886 shares of the pharmaceutical company's stNovember 16, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Position Lifted by Mizuho Securities USA LLCMizuho Securities USA LLC lifted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 289.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,393November 16, 2024 | marketbeat.comKentucky Retirement Systems Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Kentucky Retirement Systems lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 7.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,981 shares of the pharmaceutical coNovember 16, 2024 | marketbeat.comCIBC Asset Management Inc Acquires 4,432 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)CIBC Asset Management Inc grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,102 shares of theNovember 16, 2024 | marketbeat.comImpax Asset Management Group plc Has $3.46 Million Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Impax Asset Management Group plc decreased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 86.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,433 shares of the pharmaceutical compNovember 16, 2024 | marketbeat.comVertex Pharmaceuticals initiated with a Buy at CitiNovember 15, 2024 | markets.businessinsider.comCitigroup Initiates Coverage of Vertex Pharmaceuticals (VRTX) with Buy RecommendationNovember 15, 2024 | msn.comVertex Pharmaceuticals Incorporated (VRTX) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)November 15, 2024 | seekingalpha.comBroderick Brian C Acquires 3,876 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Broderick Brian C raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 51.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,460 shares of the pharmaceutical cNovember 15, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stake Increased by KBC Group NVKBC Group NV grew its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 11.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,727 shares of the pharmaceutical company'November 15, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Huntington National BankHuntington National Bank lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 39,229 shares of the pharmaceutical company's stock after sellingNovember 15, 2024 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at CitigroupCitigroup upgraded shares of Vertex Pharmaceuticals to a "strong-buy" rating in a research report on Wednesday.November 15, 2024 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Raised to Strong-Buy at StockNews.comNovember 15, 2024 | americanbankingnews.comSivik Global Healthcare LLC Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Sivik Global Healthcare LLC trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 33.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,000 shares of the pharmaceutical compNovember 14, 2024 | marketbeat.comAubrey Capital Management Ltd Purchases Shares of 6,900 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Aubrey Capital Management Ltd bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 6,900 shares of the pharmaNovember 14, 2024 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Coverage Initiated at CitigroupCitigroup assumed coverage on shares of Vertex Pharmaceuticals in a research note on Thursday. They issued a "buy" rating and a $575.00 target price on the stock.November 14, 2024 | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Pinnacle Financial Partners IncPinnacle Financial Partners Inc increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 985.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,641 shares of the pharmacNovember 14, 2024 | marketbeat.comInsider Sale at Vertex Pharmaceuticals Inc (VRTX) by EVP & CFO Charles F. Wagner Jr.November 13, 2024 | gurufocus.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Chase Investment Counsel CorpChase Investment Counsel Corp lessened its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,063 shares of the pharmaceutical coNovember 13, 2024 | marketbeat.comVictory Capital Management Inc. Has $144.37 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Victory Capital Management Inc. lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 310,414 sharNovember 13, 2024 | marketbeat.comAptus Capital Advisors LLC Has $8.70 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Aptus Capital Advisors LLC raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,716 shaNovember 13, 2024 | marketbeat.comBaillie Gifford & Co. Lowers Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Baillie Gifford & Co. cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 16.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 140,580 shares of the phNovember 13, 2024 | marketbeat.comWealthPlan Investment Management LLC Takes $635,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)WealthPlan Investment Management LLC bought a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,366 shares of the pharmaceutical compNovember 13, 2024 | marketbeat.comPrediction: This Biotech Stock Is Heading for a Once-in-a-Generation OpportunityNovember 13, 2024 | fool.comVertex Pharmaceuticals (NASDAQ:VRTX) Stock Rating Upgraded by StockNews.comStockNews.com upgraded Vertex Pharmaceuticals from a "buy" rating to a "strong-buy" rating in a report on Wednesday.November 13, 2024 | marketbeat.comCumberland Partners Ltd Grows Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Cumberland Partners Ltd lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 50.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,200 shares of the pharmaceutical company's sNovember 12, 2024 | marketbeat.comHemenway Trust Co LLC Has $18.66 Million Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Hemenway Trust Co LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 41.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,119 shares of the pharmaceutiNovember 12, 2024 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Tesla Execs are Freaking Out (Ad)It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼1.220.36▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼4317▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News BeiGene News United Therapeutics News Incyte News Royalty Pharma News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRTX Stock Alerts